DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease - Wikidata - awgldk - TriplyDB

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

http://www.wikidata.org/entity/Q30493811

about

Blood alpha-synuclein in agricultural pesticide handlers in central Washington State Cerebrospinal Fluid Amyloid β1-42, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson's Disease Modeling Parkinson's disease in the common marmoset (Callithrix jacchus): overview of models, methods, and animal care The Diagnostic and Differential Diagnosis Utility of Cerebrospinal Fluid α -Synuclein Levels in Parkinson's Disease: A Meta-Analysis Proteomics and systems biology: current and future applications in the nutritional sciences Biochemical premotor biomarkers for Parkinson's disease Emerging candidate biomarkers for Parkinson's disease: a review CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson's Disease.Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.Harnessing Cerebrospinal Fluid Biomarkers in Clinical Trials for Treating Alzheimer's and Parkinson's Diseases: Potential and Challenges Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?Expression and Transport of α-Synuclein at the Blood-Cerebrospinal Fluid Barrier and Effects of Manganese Exposure DJ-1-dependent regulation of oxidative stress in the retinal pigment epithelium (RPE)Specific changes of serum proteins in Parkinson's disease patients Decrease in plasma levels of α-synuclein is evident in patients with Parkinson's disease after elimination of heterophilic antibody interference Park7 interacts with p47(phox) to direct NADPH oxidase-dependent ROS production and protect against sepsis Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression Phosphorylated α-synuclein in Parkinson's disease.DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease Plasma apolipoprotein A1 as a biomarker for Parkinson disease Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.Targeted discovery and validation of plasma biomarkers of Parkinson's disease.Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's Disease The role of biomarkers and imaging in Parkinson's disease.Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.Salivary DJ-1 could be an indicator of Parkinson's disease progression Blood-based biomarkers for Parkinson's disease α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method Brain disposition of α-Synuclein: roles of brain barrier systems and implications for Parkinson's disease.Alterations in energy/redox metabolism induced by mitochondrial and environmental toxins: a specific role for glucose-6-phosphate-dehydrogenase and the pentose phosphate pathway in paraquat toxicity

P2860

Q23922069-293515DA-53E0-461F-BEA1-5DCD5F610AF0 Q26744782-CB0B0995-7AC6-4094-9F1D-DCD5F0F4D2D6 Q26772285-0F3589D1-9145-40D7-AEF5-8C53FA237FC6 Q26785974-64688803-6160-4C27-9805-38962588B432 Q26829598-DD9A5998-1548-4173-9800-9CE3D13B2536 Q27008467-3A4E3771-FAEA-4B28-8C61-DBB3144FD0EB Q27015018-8708D911-532E-40A6-884F-7AA14084683A Q27304608-DFCB2F77-351F-4DA5-81BD-B2D3B8658D1C Q27311994-99027440-6E21-4717-A723-F36BE31AB6CF Q27322563-B6BB852E-FCFC-47AC-B1D8-2DD1F08E2B63 Q27333275-67B83482-C860-44A2-8C15-F983C5E669E2 Q27333599-032E476F-9324-4AB3-A575-1CE76928A1ED Q27686837-4A9F14DB-FCA6-422A-BA53-05CC7A2975F1 Q28072061-B8B98E13-1E16-43B5-9484-185CEC899201 Q28082380-384B7C73-5991-4BDA-A7A0-7984E8F213CC Q28083203-E68D42EE-812F-4B28-A17D-06E04D706744 Q28395564-05AC486B-371F-4BBC-B55F-C9F20343EF5A Q28534455-2C3C8BCD-413A-4D68-B21E-8E7D4B9E56C4 Q28538260-7BC2304C-D948-4EC3-B25C-2102F6A8343B Q28545821-82199770-6B6B-454E-B2F4-E44477936034 Q28592872-B0D4815D-A8AD-4519-B0F9-6B93D1EFABA1 Q28731824-6D716804-6C4A-43B2-9876-59D942B53803 Q30405991-C49AFD9B-6AE6-433C-B9C2-C682B39BDFF8 Q30496676-FBBF7F9C-3817-4B62-8003-AF5C2881A005 Q30497763-4565C391-B2F0-429B-9EB2-8E3FFC2366CE Q30501271-0D8E926F-DF83-42D6-9259-747F74D6A719 Q30510167-5617717F-3016-4A45-A285-B6629394D278 Q30529658-77190E9C-A680-4049-8107-2798B30CAA52 Q30544798-CA187F5F-DA0C-41FD-9959-3513069E762A Q30588544-A5138480-9799-43CA-8260-202E062AC811 Q30597182-4B7BDCE4-FE7D-4130-ACE5-0DEBD35C91E7 Q30659251-CCB5DF53-0D3C-4BA4-9400-9074EC599B32 Q31041660-F9DDF914-1FFD-42F8-9F6C-B2E8C4D81A2B Q33666297-5153888C-319B-4946-8531-F56F292D6C5C Q33719372-3DBE48B5-6A56-44E7-B2D5-9DA955A304CB Q33804255-BC831A22-4294-4A95-A1A5-240988EBCC0A Q33889446-073074A9-2530-4BC0-8941-9CBB45A0061A Q33933189-D45F4096-8D8A-41D7-9699-FFAC0AF82808 Q33997655-68C3EBF9-888F-4277-BFA5-CF889D1462C6 Q34211654-F6CDE468-3985-47FF-95DC-3BF5096313A5

P2860

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

http://www.wikidata.org/entity/Q30493811

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

DJ-1 and alpha-synuclein in hu ...... markers of Parkinson's disease

@ast

DJ-1 and alpha-synuclein in hu ...... markers of Parkinson's disease

@en

type

label

DJ-1 and alpha-synuclein in hu ...... markers of Parkinson's disease

@ast

DJ-1 and alpha-synuclein in hu ...... markers of Parkinson's disease

@en

prefLabel

DJ-1 and alpha-synuclein in hu ...... markers of Parkinson's disease

@ast

DJ-1 and alpha-synuclein in hu ...... markers of Parkinson's disease

@en

P1433

Q30493811-FD25E517-47F6-425A-ACE8-A37B5BE3D6DE

P1476

Q30493811-462482C5-8DA1-4C4E-960C-E490171EDD0B

P2093

Q30493811-00576179-5EE3-4EA6-8433-72C9286BDD24

Q30493811-012DD236-C245-431C-847D-1BB7AC8C6A10

Q30493811-14929844-8B0C-4D9A-AA8C-625814CD7F45

Q30493811-40A17942-679D-4F39-A78F-2155453D59BC

Q30493811-549BA136-F6DF-4226-94C5-3E20953F1009

Q30493811-59700C51-DFE4-4ABD-B678-565A4ABE5D1A

Q30493811-5CE98650-913F-4B3E-99BB-AF8BA080E990

Q30493811-5E12157E-FB5D-44AD-9F1E-5CEFBB83C9C5

Q30493811-67C95F93-74EF-4E74-84F2-07F4F30A9881

Q30493811-697046B6-A7C3-4F05-BFB5-29304E5FA17D

P2860

Q30493811-1F6D6835-FC47-4086-A354-F560E0FAAE18

Q30493811-211FB67E-56E4-481F-A4B3-17B36B556528

Q30493811-2E4B8E8F-F95C-405E-A070-D589AE7992D3

Q30493811-3A4AB87B-D99B-440B-89A8-86C3C43EC333

Q30493811-460123B4-536B-4EC8-A882-5352A7065AD9

Q30493811-486BF2B2-E561-48C3-B6FA-1DD47FA7384D

Q30493811-5201A006-B457-4429-8006-E74CC60C50DC

Q30493811-535B810F-C01F-4C7C-BF80-EB03929247A5

Q30493811-53DF44CE-FFC4-48DC-B906-229FDE70CA96

Q30493811-5D1208B7-743E-4CB5-8ACB-58A1AF62A9B5

P304

Q30493811-5E307D76-EFBF-40C6-A2D6-6C9A72BEAB67

P31

Q30493811-02974080-868A-4E73-93F0-CB279A490DB7

P356

Q30493811-979AA82C-45F4-4F7F-ACB1-81C325F66D3D

P407

Q30493811-75C8CC8C-AC00-41E2-B759-5BE91D160F0F

P433

Q30493811-797A96BA-122E-4432-A338-5BE4C2EB00BF

P478

Q30493811-8FC7CF3B-10AB-4F59-8108-782CC7910F12

P50

Q30493811-597251C7-8798-48FF-8D32-362548AE07AC

Q30493811-F2B5E4B4-2576-4C81-8FC7-AE05428B9E1D

Q30493811-F887A08F-2080-432A-A42A-63E462F7D3C3

P577

Q30493811-277AD4B4-25D5-455D-883C-39E0FBB990F9

P5875

Q30493811-278ACF27-3726-4EB5-B260-0BA0B1F59C2B

P698

Q30493811-24C0A22A-901E-49E4-9A00-C1AF56E1A803

P921

Q30493811-13276048-A3A7-4DFE-9CAD-E375F129D94A

Q30493811-4743FDD6-84EF-4F65-A736-8CED63D15CA5

Q30493811-627385AD-87F6-4DFB-A022-E7310F58A0E3

Q30493811-78B69CB3-DDF1-4066-944E-3CECCEEDEE8C

P932

Q30493811-4ADDD8DB-AEF8-40BB-AD98-CBEE7CD2CC9C

P356

P1433

P1476

DJ-1 and alpha-synuclein in hu ...... markers of Parkinson's disease

@en

P2093

Aneeka M Hancock

http://www.w3.org/2001/XMLSchema#string

Catherine Pan

http://www.w3.org/2001/XMLSchema#string

Douglas Galasko

http://www.w3.org/2001/XMLSchema#string

Elaine R Peskind

http://www.w3.org/2001/XMLSchema#string

Geoffrey Baird

http://www.w3.org/2001/XMLSchema#string

Hyejin Hwang

http://www.w3.org/2001/XMLSchema#string

James B Leverenz

http://www.w3.org/2001/XMLSchema#string

Joseph F Quinn

http://www.w3.org/2001/XMLSchema#string

Joshua Bradner

http://www.w3.org/2001/XMLSchema#string

Kathryn A Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Staging of brain pathology related to sporadic Parkinson's disease

Progressive supranuclear palsy: where are we now?

Multiplexed particle-based flow cytometric assays.

Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases

Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cells

Synucleinopathies: clinical and pathological implications.

Alpha-synuclein and Parkinson's disease.

Platelet alpha- and gamma-synucleins in Parkinson's disease and normal control subjects.

Levodopa and the progression of Parkinson's disease.

Phosphoproteome study reveals Hsp27 as a novel signaling molecule involved in GDNF-induced neurite outgrowth.

P304

713-726

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWQ008

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 3

http://www.w3.org/2001/XMLSchema#string

P478

133

http://www.w3.org/2001/XMLSchema#string

P50

Cyrus P Zabetian

Joseph Jankovic

P577

2010-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41435395

http://www.w3.org/2001/XMLSchema#string

P698

20157014

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

cerebrospinal fluid

P932

2842513

http://www.w3.org/2001/XMLSchema#string